Ventral Hernia Mesh Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Mesh Type (Resorbable Mesh, Partially Absorbable Mesh, Non-Resorbable Mesh), By Indication (Umbilical Hernia, Epigastric Hernia, Incisional Hernia, Others), By Procedure (Open Surgery, Laparoscopic Surgery, Robotic Surgery, Others), By End Use (Inpatient Facilities, Outpatient Facilities), By Region and Competition, 2020-2030F

Market Overview

Global Ventral Hernia Mesh Devices Market was valued at USD 841.06 Million in 2024 and is expected to reach USD 1375.61 Million by 2030 with a CAGR of 8.52%. The Global Ventral Hernia Mesh Devices Market is experiencing steady growth due to the increasing burden of hernia cases, particularly ventral hernias, driven by factors such as obesity, previous abdominal surgeries, and a rising aging population. Ventral hernia mesh devices are widely used in surgical interventions to reinforce weakened abdominal muscles and prevent hernia recurrence. As surgical techniques evolve, there is a greater demand for mesh products that offer improved biocompatibility, durability, and ease of use. Surgeons are increasingly adopting mesh-based repair over traditional suture methods due to better patient outcomes and reduced recurrence rates. With healthcare systems emphasizing efficient surgical outcomes and faster patient recovery, ventral hernia mesh devices are becoming a vital component of modern hernia repair procedures.

The market is being propelled by multiple drivers, including the increasing use of minimally invasive laparoscopic surgeries, which require specialized mesh products compatible with such techniques. Technological advancements in mesh materials, such as the development of lightweight, composite, and absorbable meshes, are enhancing clinical outcomes and surgeon confidence. Patients are also becoming more aware of surgical options and demanding better post-operative quality of life, fueling demand for advanced mesh solutions. A strong focus on reducing surgical complications such as infections, chronic pain, and mesh migration is driving innovation in product design. Key manufacturers are investing in R&D to develop next-generation meshes that offer better integration with body tissues, are easier to implant, and pose fewer long-term risks, thereby strengthening market growth across healthcare systems.

Despite its promising outlook, the market faces several challenges that could hinder its potential. High costs associated with advanced mesh devices limit accessibility in price-sensitive markets and smaller healthcare settings. Variability in surgical techniques, surgeon expertise, and patient profiles often lead to inconsistent outcomes, affecting product reputation and adoption rates. Concerns over mesh-related complications, such as adhesion, rejection, or chronic discomfort, continue to impact patient and surgeon confidence, especially in light of past product recalls and litigation issues. Stringent regulatory requirements, coupled with the lengthy approval process for new devices, create entry barriers for smaller players and delay innovation rollout. Achieving global standardization in hernia repair protocols and educating surgeons on new mesh technologies are essential steps toward overcoming these hurdles and ensuring broader adoption of ventral hernia mesh devices worldwide.

Key Market Drivers

Rising Prevalence of Ventral Hernias and Related Risk Factors

The rising prevalence of ventral hernias and associated risk factors is a primary driver fueling growth in the Global Ventral Hernia Mesh Devices Market. According to StatPearls, approximately 350,000 ventral hernia repairs are performed annually in the United States alone, placing a substantial burden on healthcare systems and emphasizing the ongoing need for durable repair methods. This volume underscores not only the high clinical demand but also reflects a broader trend: ventral hernias affect roughly 1.7% of the U.S. population, with prevalence increasing to 4% among individuals over 45, reflecting aging-related tissue weakening. Such data from authoritative medical sources signal a growing market opportunity for mesh-based repair solutions worldwide.

Moreover, according to CDC data, about 600,000 ventral hernia repairs are performed annually in the U.S., reflecting both clinical need and surgical volume. Growing rates of obesity at 40.3% among U.S. adults during August 2021–August 2023 elevates intra-abdominal pressure, weakening abdominal walls and increasing hernia incidence.

Contributing significantly to hernia development, obesity continues to climb globally, creating high intra-abdominal pressure that compromises abdominal wall integrity. Aging populations in many countries further compound this issue, as age-related muscle degeneration and coexisting chronic conditions such as diabetes and COPD heighten hernia susceptibility. Lifestyle factors including repetitive heavy lifting, chronic coughing, and poor nutrition also weaken abdominal muscles, fostering a conducive environment for ventral hernias. The convergence of these risk factors has led to a sustained increase in surgical interventions, particularly mesh-supported repairs, which are increasingly preferred to reduce recurrence rates and ensure long-term structural support.

Patient awareness and engagement in hernia treatment have improved, resulting in higher elective surgery volumes. Healthcare providers now prioritize predictive approaches that combine patient risk profiles with optimal mesh selection to achieve better outcomes. The evidence-based success of mesh repairs demonstrated by reduced recurrence, decreased postoperative complications, and improved quality of life reinforces clinical confidence. This dynamic is backed by consistent procedural demand and validated by government and peer-reviewed data. Collectively, the rising frequency of hernia cases, demographic shifts, and evidence-based treatment protocols make the increasing prevalence of ventral hernias and related risk factors a pivotal growth driver for the global hernia mesh devices market.

Increasing Preference for Mesh-Based Repair Over Suture Repair

The increasing preference for mesh-based repair over traditional suture techniques is a powerful driver for the Global Ventral Hernia Mesh Devices Market. Each year, approximately 350,000 ventral hernia repair surgeries are performed in the United States alone, with costs reaching around USD 3.2 billion figures that highlight both the demand for procedures and the economic impact of complications and recurrences. Clinical evidence shows that mesh implantation delivers significantly lower recurrence rates and enhanced long-term durability compared to suture-only methods, particularly in high-tension wounds where native tissue repair is insufficient.

Surgeons, supported by a growing body of peer-reviewed literature, increasingly recommend mesh reinforcement even in moderate hernia cases, recognizing its benefits in strengthening the abdominal wall and reducing the likelihood of repeat surgeries. Patients are also more conscious of quality-of-life outcomes, favoring mesh-supported repairs for their demonstrated advantages: albeit initially more costly, they help avoid future hospitalizations and additional interventions. In this way, mesh usage aligns with value-based healthcare initiatives that prioritize cost-effectiveness and patient satisfaction.

Advancements in mesh technology including lightweight composites and partially absorbable materials have addressed prior concerns surrounding chronic pain, stiffness, and foreign body reactions, further encouraging adoption. These developments have restored both professional and patient confidence in mesh devices. As a result, hospitals are incorporating mesh-based products into standardized hernia repair protocols to streamline outcomes and meet evidence-based care standards. With a convergence of clinical, economic, and technological incentives, mesh-based repairs are firmly becoming the global standard for ventral hernia treatment, driving sustained market growth.

Technological Advancements in Mesh Materials and Design

Technological advancements in mesh materials and design are significantly driving growth in the Global Ventral Hernia Mesh Devices Market. Traditional heavyweight synthetic meshes, while effective for reinforcement, often caused issues such as chronic inflammation, infection, and poor integration. In response, companies have developed lightweight polymer-based meshes that minimize foreign body response while offering enhanced flexibility. These modern meshes, engineered to mimic natural tissue movement, lower the risk of migration and folding, improving patient comfort and surgical outcomes. Composite and dual-layer meshes combine absorbable and non-absorbable components, promoting tissue ingrowth on one side and preventing organ adhesion on the other. Features such as anti-adhesive coatings, resorbable barriers, and optimized porosity have further refined biocompatibility, supporting healing and reducing postoperative complications. Self-fixating meshes with microgrips or barbs eliminate the need for sutures or tacks, which can cause pain and nerve injury.

Cutting-edge innovations include anatomically shaped and customizable meshes tailored to patient physiology. These designs allow precise placement, especially during minimally invasive or robotic-assisted procedures. As a result of these innovations, surgeons increasingly prefer mesh-based repairs; in the United States alone, over 350,000 ventral hernia repairs are performed annually, representing a substantial potential market for advanced mesh devices. With ventral hernias affecting approximately 1.7% of the U.S. population and rising to 4% among those over 45, the demand for sophisticated reinforcement solutions continues to grow. The combination of improved materials, patient-specific design, and enhanced compatibility with emerging surgical methodologies is expanding the clinical applicability of mesh devices. Hospitals and surgeons are adopting these innovations to enhance outcomes, reduce recurrence rates, and raise procedural standards globally, firmly positioning new mesh technologies at the forefront of hernia care.

Download Free Sample Report

Key Market Challenges

High Cost of Advanced Mesh Devices Limiting Accessibility

One of the key challenges hindering the growth of the Global Ventral Hernia Mesh Devices Market is the high cost associated with advanced mesh products, which significantly limits their accessibility, especially in price-sensitive and low-resource healthcare settings. Modern mesh devices, particularly those that are lightweight, composite, biologic, or bioresorbable, are often priced at a premium due to the use of specialized materials, proprietary technologies, and extensive regulatory compliance requirements. These higher costs can be a substantial burden for hospitals operating within tight budget constraints and for patients paying out of pocket in regions lacking comprehensive health insurance coverage.

In many developing countries, healthcare providers are forced to prioritize cost over clinical innovation, often opting for traditional suture repairs or outdated mesh products with higher complication and recurrence risks. This cost-related disparity in access creates a significant gap in patient outcomes across different geographic regions. Even in developed markets, reimbursement policies do not always cover the full cost of advanced mesh implants, placing financial pressure on both healthcare institutions and patients. Surgeons may also hesitate to use premium mesh options if reimbursement rates fail to justify the investment, limiting innovation uptake despite the availability of clinically superior alternatives. As healthcare systems attempt to balance quality care with economic sustainability, the affordability of next-generation hernia mesh devices remains a major constraint that stakeholders must address to ensure broader and equitable adoption across global markets.

Variability in Surgical Techniques and Clinical Outcomes

A major challenge facing the Global Ventral Hernia Mesh Devices Market is the significant variability in surgical techniques and clinical outcomes across regions, healthcare systems, and individual surgeons. Hernia repair procedures can be performed using multiple approaches, including open surgery, laparoscopic techniques, and increasingly robotic-assisted methods. Each approach requires a different level of surgical skill, experience, and familiarity with mesh devices. The selection of mesh type, placement method (onlay, sublay, inlay, or underlay), and fixation technique varies widely among practitioners. This inconsistency leads to a broad spectrum of patient outcomes, ranging from successful recoveries to complications such as recurrence, infection, mesh migration, and chronic pain. As a result, it becomes difficult to establish standardized protocols for ventral hernia repair, which is essential for building clinical confidence and guiding purchasing decisions in hospitals.

Inconsistencies in surgical training and clinical decision-making also contribute to unpredictable results. Some surgeons may prefer traditional methods or older mesh designs due to familiarity or limited access to training on newer technologies. Variations in patient characteristics, including obesity, comorbidities, and prior surgical history, further complicate procedural planning and mesh selection. These factors create challenges in evaluating long-term efficacy and safety across diverse patient populations. The lack of uniform surgical outcomes not only affects patient satisfaction and recovery but also raises concerns among healthcare providers and payers about the cost-effectiveness of mesh-based repairs. In an increasingly data-driven healthcare environment, the absence of standardized, reproducible clinical benchmarks undermines the ability to fully assess product performance and return on investment. Addressing this challenge requires coordinated efforts in surgeon education, development of evidence-based guidelines, and implementation of surgical registries to track outcomes and refine best practices globally. Until this variability is reduced, it will continue to hinder the full potential and adoption of advanced ventral hernia mesh solutions.

Key Market Trends

Rising Demand for Lightweight and Composite Mesh Materials

A significant trend shaping the Global Ventral Hernia Mesh Devices Market is the rising demand for lightweight and composite mesh materials. Traditional heavyweight synthetic meshes, while effective in reinforcing the abdominal wall, have been associated with complications such as chronic pain, infection, inflammation, and foreign body sensation. These issues have prompted both surgeons and patients to seek alternatives that offer improved biocompatibility and comfort. Lightweight mesh materials, often constructed with reduced polypropylene content and larger pore sizes, are designed to integrate more naturally with host tissues. This design minimizes the body’s inflammatory response, reduces fibrosis, and promotes better tissue regeneration, ultimately improving post-operative outcomes and patient satisfaction.

Composite meshes, which combine absorbable and non-absorbable components, are gaining traction due to their ability to provide initial strength during healing while gradually degrading the absorbable portion to reduce long-term foreign material retention. These advanced meshes are particularly beneficial in cases requiring intraperitoneal placement, where anti-adhesion barriers are needed to protect internal organs. Surgeons are adopting these materials for both open and minimally invasive procedures, as they are easier to handle, conform better to the anatomy, and are associated with fewer long-term complications. Continuous innovation by manufacturers to enhance mesh design, porosity, flexibility, and barrier coatings is further accelerating this trend. The demand for patient-centric, low-risk mesh solutions that support faster recovery and improved quality of life is expected to drive continued growth in the lightweight and composite mesh segment, making it one of the most dynamic areas within the ventral hernia mesh devices market.

Increased Adoption of Laparoscopic and Robotic-Assisted Hernia Repair

A prominent trend driving the Global Ventral Hernia Mesh Devices Market is the increased adoption of laparoscopic and robotic-assisted hernia repair techniques. Surgeons and healthcare providers are steadily shifting away from traditional open surgeries due to the numerous clinical and operational advantages offered by minimally invasive approaches. Laparoscopic hernia repair involves smaller incisions, reduced blood loss, quicker recovery times, and shorter hospital stays, which translate to lower healthcare costs and improved patient satisfaction. As patient demand grows for procedures that minimize post-operative discomfort and speed up return to normal activities, hospitals are investing in technologies and training programs that support advanced surgical methods.

Robotic-assisted hernia repair is gaining momentum as it offers enhanced precision, better visualization, and greater surgeon dexterity, particularly in complex ventral hernia cases where anatomical challenges or recurrence risks are high. Robotic platforms allow for meticulous mesh placement and fixation, reducing the chances of complications such as mesh migration, infection, or chronic pain. Manufacturers are responding to this trend by developing mesh devices specifically engineered for use in robotic and laparoscopic settings, with features like self-fixation, improved pliability, and compatibility with smaller instruments. As minimally invasive techniques continue to gain clinical endorsement and technological advancements lower the learning curve, the integration of robotic and laparoscopic solutions into standard hernia care protocols is expected to accelerate, shaping the future of ventral hernia repair worldwide.

Segmental Insights

Mesh Type Insights

Based on the Mesh Type, Non-Resorbable Mesh emerged as the dominant segment in the Global Ventral Hernia Mesh Devices Market in 2024. This is due to its widespread clinical acceptance, proven durability, and superior tensile strength. These meshes, typically made from materials like polypropylene or expanded polytetrafluoroethylene (ePTFE), are designed to provide long-term reinforcement of the abdominal wall, making them particularly suitable for large or complex ventral hernias. Surgeons across the globe continue to rely on non-resorbable meshes for their ability to maintain structural integrity over time and reduce the risk of hernia recurrence. The long-term permanence of non-resorbable mesh materials provides consistent support in high-tension areas, offering favorable outcomes in patients with risk factors such as obesity, prior surgeries, or chronic conditions. These meshes are compatible with both open and minimally invasive surgical techniques, adding to their versatility in clinical settings.

Indication Insights

Based on the Indication, Incisional Hernia emerged as the dominant segment in the Global Ventral Hernia Mesh Devices Market in 2024. This dominance is primarily due to its high prevalence among patients undergoing abdominal surgeries. Incisional hernias occur at the site of a previous surgical incision, where the abdominal wall becomes weakened or fails to heal properly. With rising global surgical volumes particularly for procedures like laparotomies, bariatric surgeries, and organ transplants; the incidence of incisional hernias continues to grow, driving consistent demand for mesh-based repair solutions. The preference for mesh implantation in incisional hernia repair is largely attributed to its effectiveness in reducing recurrence rates compared to suture-only techniques. Surgeons widely recommend mesh reinforcement for such cases, especially when the hernia defect is large or complex. Technological advancements in mesh design, including options tailored for high-tension incisional sites and minimally invasive placement, have further contributed to the segment’s growth.

Download Free Sample Report

Regional Insights

North America emerged as the dominant region in the Global Ventral Hernia Mesh Devices Market in 2024. This is primarily driven by its advanced healthcare infrastructure, high surgical volumes, and widespread adoption of technologically advanced medical devices. The United States, in particular, leads the region due to its high prevalence of ventral and incisional hernias, rising obesity rates, and a growing aging population—all of which are significant risk factors for hernia development. The region also benefits from the strong presence of leading mesh device manufacturers, robust reimbursement frameworks, and early adoption of innovative surgical techniques, including robotic-assisted and laparoscopic hernia repair. Healthcare providers in North America are highly trained in mesh-based repair procedures, and clinical guidelines strongly support the use of mesh for ventral hernia treatment to reduce recurrence rates.

Asia-Pacific emerged as the fastest growing region in the Global Ventral Hernia Mesh Devices Market during the forecast period. This is driven by the rapid expansion of healthcare infrastructure and increasing awareness about advanced surgical treatments. Countries such as India, China, South Korea, and Indonesia are witnessing a surge in elective and emergency surgical procedures due to improved access to hospitals and skilled medical professionals. Government initiatives aimed at strengthening secondary and tertiary care facilities are enabling more patients to undergo hernia repair surgeries, particularly in urban and semi-urban areas. With a growing middle-class population and rising health insurance coverage, patients are now more likely to opt for mesh-based hernia repair, which was previously limited by financial constraints. Furthermore, local and international manufacturers are investing in the region to set up production facilities and distribution networks, resulting in increased availability of cost-effective mesh devices tailored to local surgical preferences.

Recent Developments

• In April 2025, BD (Becton, Dickinson and Company) announced the U.S. FDA 510(k) clearance and commercial launch of its Phasix ST Umbilical Hernia Patch, a fully absorbable mesh specifically designed for umbilical hernia repair procedures. This advanced solution is engineered to deliver reliable reinforcement while minimizing long-term foreign body presence. By offering a fully absorbable structure, the patch supports natural tissue healing and aims to reduce the risk of chronic complications often associated with permanent synthetic meshes.
• In October 2024, Momentis Surgical Ltd., a medical device company specializing in robotic-assisted surgery, announced that it has received FDA 510(k) clearance for its Anovo robotic surgical platform to be used in single-site, abdominal access ventral hernia repair procedures. This new clearance marks a significant expansion of the Anovo platform’s clinical application, which was previously approved for natural orifice laparoscopic-assisted transvaginal benign gynecological surgeries. The Anovo system is designed to replicate human-like movements and offer greater precision in confined anatomical spaces, aiming to improve surgical outcomes and reduce recovery times.
• In March 2024, Deep Blue Medical Advances, based in Durham, is expanding its innovative hernia repair technology to new surgical applications, building on the success of its T-Line Hernia Mesh. This advanced product has already proven effective in preventing hernia recurrence following abdominal hernia repair surgeries. Looking ahead, the company plans to launch a series of new products over the next two years, broadening its offering for soft tissue surgeries.
• In February 2024, RTI Surgical, Inc. completed the acquisition of Cook Group Incorporated, a strategic move aimed at strengthening its capabilities in both surgical and regenerative medicine. This acquisition significantly expands RTI Surgical’s portfolio of biologic and synthetic products, with a key emphasis on applications in hernia repair and wound management. By integrating Cook’s technologies and resources, RTI is positioned to accelerate innovation and deliver a broader spectrum of customizable solutions for soft tissue reconstruction, reinforcing its competitive edge in the global surgical mesh devices market.
• In June 2023, Advanced Medical Solutions Limited secured FDA approval for its LiquiFix FIX8 and LiquiFix Precision Hernia Mesh Fixation Devices, marking a significant advancement in hernia surgery technology. These devices utilize a proprietary liquid adhesive technology that allows mesh to be fixed with broader contact points during both laparoscopic and open procedures. Unlike traditional tacking systems, which may cause nerve irritation and post-operative pain, LiquiFix aims to enhance fixation while improving patient comfort and clinical outcomes.

Key Market Players

• Medtronic plc
• Becton, Dickinson and Company (BD)
• Meril Life Sciences Pvt. Ltd.
• Novus Scientific AB
• B. Braun SE
• TELA Bio, Inc.
• BG Medical LLC
• Integra LifeSciences Corporation
• W. L. Gore & Associates, Inc.
• Atrium Medical

Report Scope:

In this report, the Global Ventral Hernia Mesh Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Ventral Hernia Mesh Devices Market, By Mesh Type:

o   Resorbable Mesh

o   Partially Absorbable Mesh

o   Non-Resorbable Mesh

• Ventral Hernia Mesh Devices Market, By Indication:

o   Umbilical Hernia

o   Epigastric Hernia

o   Incisional Hernia

o   Others

• Ventral Hernia Mesh Devices Market, By Procedure:

o   Open Surgery

o   Laparoscopic Surgery

o   Robotic Surgery

o   Others

• Ventral Hernia Mesh Devices Market, By End Use:

o   Inpatient Facilities

o   Outpatient Facilities

• Ventral Hernia Mesh Devices Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ventral Hernia Mesh Devices Market.

Available Customizations:

Global Ventral Hernia Mesh Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Ventral Hernia Mesh Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]